{"schema_version":"secwatch.filing_event.v1","accession":"0001157523-22-001106","form_type":"8-K","ticker":"CVSA","cik":"0000730464","company_name":"Covista Inc.","filed_at":"2022-08-11T23:59:59+00:00","discovered_at":"2026-05-14T18:03:58.041170+00:00","generated_at":"2026-06-24T01:12:08.806343+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Adtalem Q4 revenue +61.6% to $361.2M; FY2022 adj. EPS $3.24 (+40% YoY); FY2023 guidance $3.95-$4.20","bullets":["Q4 revenue $361.2M (+61.6% YoY); GAAP EPS $0.18 flat; adjusted EPS $1.31 vs $0.48 YoY.","FY2022 GAAP EPS $6.57; adjusted EPS $3.24, up 40% YoY; adjusted EBITDA margin 24.0% vs 22.4%.","Gross debt reduced by $394.1M in Q4 (31.4%); balance sheet strengthened.","FY2023 guidance: revenue $1.38B-$1.45B; adjusted EPS $3.95-$4.20.","Chamberlain enrollment -5.8% YoY; Walden enrollment -9.5%; Medical/Vet enrollment +3.5%."],"urls":{"canonical":"https://secwatch.observer/filing/0001157523-22-001106","json":"https://secwatch.observer/filing/0001157523-22-001106.json","markdown":"https://secwatch.observer/filing/0001157523-22-001106.md","text":"https://secwatch.observer/filing/0001157523-22-001106.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/730464/000115752322001106/0001157523-22-001106-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/730464/000115752322001106/a52809088.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T01:12:08.806343+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}